Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts

被引:0
|
作者
GarciaLloret, MI [1 ]
Yui, J [1 ]
WinklerLowen, B [1 ]
Guilbert, LJ [1 ]
机构
[1] UNIV ALBERTA,DEPT MED MICROBIOL & IMMUNOL,EDMONTON,AB T6G 2H7,CANADA
关键词
D O I
10.1002/(SICI)1097-4652(199605)167:2<324::AID-JCP17>3.0.CO;2-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the placenta, as in other organs, the development and maintenance of the differentiated phenotype depend on a balance between cell proliferation, maturation, and death. We are interested in the mechanisms that regulate the survival and differentiation of placental trophoblasts and have recently demonstrated that the inflammatory cytokines tumor necrosis factor alpha (TNF alpha) and gamma interferon (IFN gamma) act in concert to induce apoptotic cell death in normal cytotrophoblasts in culture. In this report we show that exposure to epidermal growth factor (EGF), a 6,700 dalton polypeptide that is abundantly expressed in maternal and fetal tissues, blocks the in vitro TNF/IFN-induced cytotoxicity of human cytotrophoblasts and syncytiotrophoblasts from normal term placentas. This antagonistic effect is dose-related (10(-10) M EGF, half-maximal) and proceeds via the interruption of an early step in the cytokine-induced apoptotic response. These observations suggest a novel role for EGF in normal placental development and indicate that the interplay between EGF, TNF alpha, and IFN gamma may determine the rate of trophoblast growth and renewal during gestation. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:324 / 332
页数:9
相关论文
共 50 条
  • [1] Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts
    Payne, SG
    Brindley, DN
    Guilbert, LJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 180 (02) : 263 - 270
  • [2] Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor
    Levy, R
    Smith, SD
    Chandler, K
    Sadovsky, Y
    Nelson, M
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 278 (05): : C982 - C988
  • [3] Cytokine-induced apoptosis inhibitor 1 inhibits the growth and proliferation of multiple myeloma
    Wang, Xiaobo
    Pan, Jingxuan
    Li, Juan
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2056 - 2062
  • [4] Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor
    Nelin, LD
    Chicoine, LG
    Reber, KM
    English, BK
    Young, TL
    Liu, YS
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (04) : 394 - 401
  • [5] Epidermal growth factor inhibits somatostatin-induced apoptosis
    Thompson, JS
    JOURNAL OF SURGICAL RESEARCH, 1999, 81 (01) : 95 - 100
  • [6] Crosstalk between cytokine-induced apoptosis and cytokine-induced senescence in human cancer cells
    Burkhart, F.
    Rentschler, M.
    Weidemann, S.
    Braumueller, H.
    Bauer, B.
    Roecken, M.
    Wieder, T.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E86 - E87
  • [7] Human cytomegalovirus inhibits cytokine-induced macrophage differentiation
    Gredmark, S
    Tilburgs, T
    Söderberg-Nauclér, C
    JOURNAL OF VIROLOGY, 2004, 78 (19) : 10378 - 10389
  • [8] Glutamine inhibits cytokine-induced apoptosis in human colonic epithelial cells via the pyrimidine pathway
    Evans, ME
    Jones, DP
    Ziegler, TR
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (03): : G388 - G396
  • [9] Epidermal growth factor abrogates hypoxia-induced apoptosis in cultured human trophoblasts through phosphorylation of BAD serine 112
    Humphrey, Rachel G.
    Sonnenberg-Hirche, Christina
    Smith, Steven D.
    Hu, Chaobin
    Barton, Aaron
    Sadovsky, Yoel
    Nelson, D. Michael
    ENDOCRINOLOGY, 2008, 149 (05) : 2131 - 2137
  • [10] CYTOKINE-INDUCED EXPRESSION OF TRANSFORMING GROWTH FACTOR-ALPHA AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN NEONATAL SKIN EXPLANTS
    VALYINAGY, I
    JENSEN, PJ
    ALBELDA, SM
    RODECK, U
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (03) : 350 - 356